ライフサイエンスコーパス: B-cell epitope

1 asting, high-avidity Ab response against the B cell epitope.

2 aining a single amino acid substitution in a B cell epitope.

3 antibody to a second, independent native ZP3 B cell epitope.

4 es as the carrier for a defined heterologous B cell epitope.

5 (isoleucine) were implicated in a pathogenic B cell epitope.

6 clonal antibody that targets a protective Ft B cell epitope.

7 d particle is known to contain a predominant B-cell epitope.

8 minal sugar of the Ogawa LPS is a protective B-cell epitope.

9 SARS-CoV-2 and identify putative T cell and B cell epitopes.

10 4(+) T cell epitopes as well as CD8(+) T and B cell epitopes.

11 ogenic autoantibodies gain access to cryptic B cell epitopes.

12 mily, resulting in the expression of variant B cell epitopes.

13 ecule contains important CD8(+), CD4(+), and B cell epitopes.

14 tional structures and carbohydrate chains to B cell epitopes.

15 a novel BLAST-based method to predict linear B cell epitopes.

16 g state-of-the-art methods to predict linear B cell epitopes.

17 e, are known or expected to contain multiple B cell epitopes.

18 s to large-protein Ags that display numerous B cell epitopes.

19 elper epitopes genetically linked to defined B cell epitopes.

20 y in regions corresponding to defined linear B-cell epitopes.

21 vaccine carrier platforms for heterologous, B-cell epitopes.

22 These areas are commonly dubbed B-cell epitopes.

23 falciparum will need to contain both T- and B-cell epitopes.

24 at positions 44 to 63) contained both T- and B-cell epitopes.

25 the recombinant antigen contained T-cell and B-cell epitopes.

26 entral hypervariable region encoding variant B-cell epitopes.

27 the presence of immunogenic conserved linear B-cell epitopes.

28 RAP-1 homolog did not contain cross-reactive B-cell epitopes.

29 y distinct MSP-2 molecules which bear unique B-cell epitopes.

30 nces (VS1 to VS4) harboring serovar-specific B-cell epitopes.

31 rly for the identification of conformational B-cell epitopes.

32 , with potential positive selection sites on B-cell epitopes.

33 ediction tools were used to identify LASV GP B-cell epitopes.

34 ggested the presence of conserved and unique B-cell epitopes.

35 fold to present conformationally constrained B-cell epitopes.

36 ant immunotoxins by identifying and removing B-cell epitopes.

37 immunodominant HLA class I, HLA class II and B- cell epitopes.

38 only low levels of antibodies to inhibitory B-cell epitope 1 (iB-1), an inhibitory epitope in RAP-1(

39 a vaccine candidate with 13 highly antigenic B-cell epitopes, 19 HTL antigenic epitopes, and 18 CTL e

40 Applying reliable software to predict B-cell epitopes, 3 and 5 regions were found for NS5A and

41 T-B MAPs displaying B-cell epitopes 304 to 319 (MAP304) or 305 to 319 (MAP30

42 posed vaccine is armed with 6-16 mers linear B-cell epitopes, 4-9 mer CTL epitopes, and 8-15 mer HTL

43 a 694aa multi-epitope vaccine containing 16 B-cell epitopes, 82 CTL epitopes and 89 HTL epitopes, wh

44 ell determinant associated with a 12-residue B cell epitope, a process termed somatic transgene immun

45 nses against foreign antigens, we tested two B-cell epitopes: a novel neutralizing B-cell epitope, de

46 Active immunotherapy with conformational B cell epitopes affords the possibility of generating an

47 taining only B-tail-C3dg and lacking the TNF B cell epitope also showed improvements in both models,

48 to apo- and holo-protein were correlated to B-cell epitope analysis.

49 t the same polymorphism may control both the B cell epitope and constitute the MHC-bound peptide, we

50 anched core with a peptide module containing B cell epitopes and a universal T cell epitope of the Pl

51 esponse is triggered by recognition of T and B cell epitopes and is influenced by "danger" motifs tha

52 asizing the significance of virion-dependent B cell epitopes and the limitations of envelope protein-

53 acid repeats that comprise a surface-exposed B-cell epitope and (ii) the presence of a 32-amino-acid

54 es in surface electrostatic potential of HLA B-cell epitopes and applied this to explain HLA Bw4 and

55 identified in this study are immunodominant B-cell epitopes and may represent good candidates for se

56 Complexing Alt a 1 to RA masked its IgE B-cell epitopes and reduced its IgE-binding capacity.

57 sed to predict the presence of discontinuous B-cell epitopes and to confirm the molecular binding sta

58 One such polymorphic locus formed part of a B cell epitope, and antibodies from exposed individuals

59 ents to determine B cell domain specificity, B cell epitopes, and the relative importance of linear a

60 cific modelling for the prediction of linear B-cell epitopes, and the challenges faced when building

61 The link between B cell epitopes, antigen presentation, and disease onset

62 B cell epitope sequences and considered as a B cell epitope any peptide sequence producing ungapped B

63 ural pan DR epitope (PADRE) and carbohydrate B cell epitopes are demonstrated to be potent immunogens

64 Up to 90% of B-cell epitopes are discontinuous in nature, yet most pr

65 However, gp45 B-cell epitopes are highly polymorphic among B. bigemina

66 Pseudomonas exotoxin A, in which immunogenic B-cell epitopes are silenced.

67 ort peptide antigens falsely classifies many B-cell epitopes as non-epitopes.

68 y synthesize and deliver multiple T-cell and B-cell epitopes as the constituents of a single immunoge

69 pilin glycan, was found to be a major linear B-cell epitope, as determined by peptide epitope mapping

70 e murine Ab response as a model to study the B cell epitopes associated with PE38.

71 a prime vaccine candidate, but variation in B-cell epitopes at the dimer interface of DBP leads to i

72 imeric RHDV VLPs by insertion of the foreign B-cell epitopes at three different locations within VP60

73 59R), Tau (AV-1980R) or Abeta/tau (AV-1953R) B cell epitopes, based on immunogenic MultiTEP platform

74 B-cell epitopes (BCEs) play a pivotal role in the develo

75 ide biosynthetic approach, 30 precise linear B-cell epitopes (BCEs) were mapped on E6, E7 and L1 prot

76 e demonstrate that short 7-12-aa peptides of B-cell epitopes bind antibodies poorly; thus, epitope ma

77 e (same T cell epitopes) and structure (same B cell epitopes) but with different susceptibilities to

78 was chosen because it contains a functional B cell epitope, but lacks known T cell epitopes.

79 t a peptide vaccine containing minimal T and B cell epitopes composed of only 5 amino acids (N, A, V,

80 e surface as well as rhoptries and expresses B-cell epitopes conserved among otherwise antigenically

81 All four dominant B-cell epitopes contained polymorphic residues, three of

82 ecies specific and identified three distinct B-cell epitopes containing sequences DRYI, CHPSDGKC, and

83 t a useful approach to map the discontinuous B cell epitope-containing regions of proteins.

84 Identification of surface-accessible B-cell epitopes could be important to efforts to develop

85 -epitopes, are over-represented in published B-cell epitope datasets that are commonly used for devel

86 MOMP B-cell epitopes defined by 22 different serovar-specific

87 red binding kinetics identified "functional" B-cell epitopes, defined as those residues contributing

88 humoral responses against displayed foreign B-cell epitopes, demonstrated by both, in vitro neutrali

89 d an Ad-based malaria vaccine by inserting a B cell epitope derived from a Plasmodium yoelii circumsp

90 were genetically fused to an immunodominant B cell epitope derived from the N-terminal region I and

91 d a lipopeptide oral delivery system using a B-cell epitope derived from the aspartic protease Na-APR

92 profile, and immunogenicity of two chimeric, B-cell epitopes derived from the human epidermal growth

93 ed two B-cell epitopes: a novel neutralizing B-cell epitope, derived from feline calicivirus capsid p

94 A B cell epitope-derived peptide of Phl p 1 devoid of alle

95 uently boosted with molecules containing the B cell epitope-derived peptide without carrier or linked

96 pCol(28-40); that is, 1) elimination of the B cell epitope, either by substitution of the critical r

97 approach for quantitating differences in HLA B-cell epitope electrostatic potential.

98 ent malaria models have shown that CS repeat B-cell epitopes expressed in a recombinant hepatitis B v

99 The importance of conformational B cell epitopes for pathogenic autoantibodies recapitula

100 1, a novel conjugate of Abeta1-15 peptide (a B-cell epitope fragment) conjugated to an immunogenic ca

101 The B cell component consists of just 3 B cell epitopes from the ectodomain of glycoproteins L a

102 eptide system containing B-tail-tagged C3dg, B cell epitopes from TNF, and the universal T cell epito

103 We use a B-cell epitope from Bacillus anthracis protective antige

104 enovirus 5 (Ad5) recombinant that displays a B-cell epitope from the circumsporozoite protein (CSP) o

105 MAP (T3-CS-T1) containing T3-T1 and a potent B-cell epitope from the circumsporozoite protein central

106 rus capsid protein, and a well characterized B-cell epitope from the extracellular domain of influenz

107 nt BepiPred-2.0, a web server for predicting B-cell epitopes from antigen sequences.

108 date, termed ICC-1132, which contains T- and B-cell epitopes from the repeat region and a universal T

109 sis for the cryptic nature (crypticity) of a B cell epitope harbored by an autoantigen is unknown.

110 Our results show that this novel EGFR B cell epitope has great potential to be used as a vacci

111 ubsequent transfusion with RBCs expressing a B-cell epitope (hen egg lysozyme [HEL]) fused to (OVA)(3

112 een mounted an antibody response against the B-cell epitope higher than mice receiving the gene codin

113 oligomannose glycans on Env shields peptidic B cell epitopes, impedes the presentation of T helper ce

114 Targeting an appropriate B cell epitope in pathological tau could in theory produ

115 Second, B cells specific to the peptidic B cell epitope in pCol(28-40) were absent among expandin

116 The structure revealed a B cell epitope in the HA head domain trimer interface (T

117 ane protein (MOMP) contains serovar-specific B cell epitopes in four regions of the molecule whose am

118 Convergence of T and B cell epitopes in H1'(22-42) and its ability to elicit

119 The amino acid sequences of four putative B cell epitopes in the fusion (E1) protein of the rubell

120 itope mapping revealed major and minor T and B cell epitopes in the N-terminal, first, and second loo

121 ug delivery vehicle, T cell responses, T and B cell epitopes in the protein drug, and the associated

122 Moreover, the proximity of TH and B cell epitopes in this restriction may have to be consi

123 rs, we investigated how the accessibility of B cell epitopes in vivo influences the development of gl

124 The linear B-cell epitope in naturally exposed P. vivax patient was

125 ised against a peptide derived from a linear B-cell epitope in the N-terminal region of gelsolin iden

126 A, S462A, and D465A mutations targeting on a B-cell epitope in the OTU domain region generated the vi

127 mal model studies are identifying T-cell and B-cell epitopes in FVIII and characterizing the presenta

128 sed identification of individual immunogenic B-cell epitopes in major antigens of a pathogen remains

129 g assays demonstrated the presence of unique B-cell epitopes in MSA-2a(1), -2b, and -2c.

130 ole of TCP presentation in the generation of B-cell epitopes in order to optimize TcpA-based cholera

131 297 to 314) comprises a region of end-to-end B-cell epitopes in some serovars of the B and F/G serogr

132 s overcome by inclusion of additional TH and B-cell epitopes in the immunizing protein.

133 Cross-reactive B-cell epitopes in the PA-binding domains of whole rLF a

134 st of these antigens showed conserved T- and B-cell epitopes in the parasite population.

135 ion and amino acid composition of all of the B-cell epitopes in the remaining 25-kDa portion of Pseud

136 sults in which we identify and silence human B-cell epitopes in the RIT HA22.

137 We previously identified seven major mouse B-cell epitopes in the toxin, and subsequently silenced

138 The presence of linear B-cell epitopes in the V protein was investigated by usi

139 amino acid residues which form autoreactive B-cell epitopes in this molecule.

140 ne PvMSP1P-19-specific antibody function and B-cell epitopes in vivax patients, five monoclonal antib

141 nd their deamidated forms, as immunodominant B-cell epitopes in wheat and related cereal proteins.

142 rovide useful but incomplete descriptions of B-cell epitopes, indicating that increased efforts to fu

143 is currently difficult, because the specific B-cell epitopes involved in toxin neutralization have no

144 Elimination of B-cell epitopes is a promising approach to the productio

145 Accurate prediction of B-cell epitopes is an important goal of computational im

146 Identifying B-cell epitopes is critical in vaccine design, developme

147 rom a linear sequence window similarity to a B-cell epitope-like 3D surface similarity window which b

148 T and B cell epitope mapping revealed major and minor T and B

149 Linear B cell epitope mapping showed that serum antibodies reco

150 zing data on more than 900 peptides used for B-cell epitope mapping of immunodominant proteins of Chl

151 n contrast, researchers typically choose for B-cell epitope mapping short peptide antigens in antibod

152 B-cell epitope mapping showed that compared to sera from

153 B-cell epitope mapping with overlapping peptides, and cr

154 of these studies showed that the B27.29 MUC1 B-cell epitope maps to two separate parts of the glycope

155 Antigenic variation in MSP2 Th cell and B cell epitopes may contribute to immune evasion that al

156 Knowledge of the B-cell epitopes may contribute to the understanding of i

157 el CD4(+) T-cell epitopes as well as a novel B-cell epitope, Meu10, which encodes a glycosylphosphati

158 anti-GBM Ab was not related to the peptidic B cell epitope nested in pCol(28-40); that is, 1) elimin

159 ope vaccine that contains the immunodominant B cell epitope of Abeta in tandem with the synthetic uni

160 laria repeat peptide containing a protective B cell epitope of Plasmodium falciparum, the most lethal

161 eptide (PPPRMPPP) with similarity to a major B cell epitope of the snRNP core protein B were identifi

162 luenza viruses expressing the immunodominant B cell epitope of this CS protein produced high titers o

163 of neutralizing antibodies to conformational B cell epitopes of MSP119 Here, using the PfMSP1/8 const

164 itope vaccines, containing CTL, Th cell, and B cell epitopes of the human papillomavirus type 16.

165 ggests the hybrids to have the discontinuous B cell epitopes of the natural Ag 5 but with an altered

166 h a peptide vaccine containing minimal T and B cell epitopes of the Plasmodium falciparum circumsporo

167 ntibody LA-2 defines an important protective B-cell epitope of OspA against which protective sera hav

168 ts of the sequence Asn-Ala-Asn-Pro (NANP), a B-cell epitope of P.falciparum sporozoites, induced anti

169 ks, and it underlies the cryptic nature of a B-cell epitope of the alpha3.alpha4.alpha5 hexamer, impl

170 The 150HA159 represents a major B-cell epitope of the HA protein.

171 ay peptide libraries in determining dominant B-cell epitopes of allergens, in developing mimotope imm

172 l of the present study is to identify linear B-cell epitopes of EF and to determine the relative cont

173 The primary B-cell epitopes of factor VIII (fVIII) are in the A2 and

174 Additionally, no iSNV enrichment within B-cell epitopes of GP has been observed.

175 amework is shown to reliably identify linear B-cell epitopes of human-adapted viruses given protein s

176 he present study were to identify sequential B-cell epitopes of LF and to determine the capacity of t

177 a branched peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum CS protein elic

178 Pol expressed in insect cells, we mapped the B-cell epitopes of Pol recognized by these MAbs to amino

179 B-cell epitopes of PvMSP1P-19 domains were evaluated by

180 rane protein contains important neutralizing B-cell epitopes of relevance for antibody-mediated prote

181 epitope polypeptide that contains T-cell and B-cell epitopes of reported novel potential vaccination

182 Identification of the most protective B-cell epitopes of TcpA within a particular peptide and

183 Synthetic peptide vaccines targeting B-cell epitopes of the extracellular domain of the HER-2

184 candidate targeting the dominant T-cell and B-cell epitopes of the immune system.

185 c antibody repertoires to the immunodominant B-cell epitopes of the major peanut allergens Ara h 1 to

186 fective vaccine must target conserved T- and B-cell epitopes of the virus.

187 ctive vaccine should target conserved T- and B-cell epitopes of the virus.

188 In this study, the B cell epitopes on melanin-concentrating hormone recepto

189 Computer prediction of the potential B cell epitopes on melanin-concentrating hormone recepto

190 n by identifying and eliminating most of the B cell epitopes on PE38.

191 We have previously mapped the T and B cell epitopes on the alpha-subunit of acetylcholine re

192 Computer analysis of the potential B cell epitopes on tyrosinase revealed that the epitope

193 In this study we have determined the B cell epitopes on tyrosinase which are recognized by th

194 -CSF is driving the autoantibodies and not a B-cell epitope on a pathogen cross-reacting with GM-CSF.

195 with plague, suggesting that this protective B-cell epitope on rV is conserved between these three sp

196 including the fact that the key neutralizing B-cell epitopes on RTA have not been fully defined.

197 ever, in the absence of cross-reactive T and B cell epitopes, one lung infection can modify immunity

198 than mice receiving the gene coding for the B-cell epitope only.

199 substitution of the critical residues of the B cell epitope or by truncation, failed to abrogate anti

200 ied autoantibodies (amAb) against linear ZP3 B cell epitopes outside the peptide immunogen.

201 Conserved B-cell epitopes overlapping the CD81 receptor-binding si

202 adjuvant by noncovalently assembling a T and B cell epitope peptide into nanofibers using a short C-t

203 determinant that enhances the response to a B-cell epitope peptide of Plasmodium falciparum expresse

204 ore, the results suggest that conformational B cell epitopes play a more significant role in ovomucoi

205 bly several freely available structure-based B cell epitope prediction programs can identify already

206 B cell epitope prediction tools are crucial for designin

207 AbEpiTope-1.0, a tool for antibody-specific B cell epitope prediction, using AlphaFold for structura

208 ts that are commonly used for development of B-cell epitope prediction approaches from protein antige

209 comes the well known inaccuracy of in silico B-cell epitope prediction from primary protein sequences

210 ins was conducted to assess whether existing B-cell epitope prediction methods, combined with compreh

211 In addition, a new B-cell epitope prediction tool was added, and the homolo

212 of eight new tools were added, including two B-cell epitope prediction tools, four T-cell epitope pre

213 For B-cell epitope prediction, the most effective approach i

214 mproved datasets for evaluation of in silico B-cell epitope prediction.

215 We developed SEPIa, a B-cell epitope predictor from the protein sequence, whic

216 ng the limitations of SEPIa and of all other B-cell epitope predictors are discussed.

217 exhibit immunogenicity, whereby a variety of B-cell epitopes, predominantly in the amino terminus of

218 This study identifies a major B cell epitope present on the apoptotic but not the inta

219 e Database, we found that only 31% (8/26) of B-cell epitopes present in recently circulating H1N1 str

220 The identified immunodominant B cell epitopes provide a better understanding of immune

221 that, inasmuch as contiguity between T- and B-cell epitopes provides enough signaling capacity to tr

222 against hybrid ubiquitin presenting the HIV B cell epitope reacted specifically with the foreign epi

223 specific T cell help by cross-linking of the B cell epitope receptor.

224 ng homology between the pathogenic human MPO B cell epitope recognized by ANCA in patients with acute

225 d envelope protein containing several linear B cell epitopes recognized by neutralizing antibody.

226 Despite many studies on B-cell epitopes recognized by antibodies, little is know

227 We proposed that B cell epitope region of HCMV phosphoprotein 65 (HCMVpp6

228 d to T cell determinants located outside the B cell epitope region, because processing/presentation o

229 n disorder tendency is the best indicator of B-cell epitope regions for chlamydial and published data

230 gen is available, the accurate prediction of B-cell epitopes remains challenging.

231 Reliable prediction of antibody, or B-cell, epitopes remains challenging yet highly desirabl

232 In silico identification of linear B-cell epitopes represents an important step in the deve

233 eluted anti-GBM Ab recognized conformational B cell epitope(s) of multiple native GBM proteins.

234 on of Ag 5 was found to contain its dominant B cell epitope(s).

235 tabase upon a dataset of 62,730 known linear B cell epitope sequences and considered as a B cell epit

236 ith antibiotic-resistant organisms, and some B-cell epitopes should be included in a subunit vaccine.

237 th the peptide vaccine or treatment with the B cell epitopes significantly reduced tumor growth in bo

238 Ag, in addition to within a known protective B-cell epitope (so-called group a determinant of HBsAg 1

239 framework to predict variable-length linear B-cell epitopes specific for human-adapted viruses with

240 B-cell epitope specificity on food allergens is highly r

241 These results present a new murine model of B cell epitope spreading and lupus autoimmunity induced

242 des harboring T cell epitopes can initiate a B cell epitope spreading cascade within the snRNP comple

243 These data implicate B cell epitope spreading in antibody-mediated pathogenes

244 rabbits develop anti-Sm autoantibodies with B cell epitope spreading of the autoimmune response as w

245 cipitation assays showed that intermolecular B cell epitope spreading to U1RNA-associated A ribonucle

246 on SmD, indicating a lack of intramolecular B cell epitope spreading within SmD.

247 ersified anti-GBM antibody response through "B cell epitope spreading." In this study, an expansion o

248 In DR2, DR3, and DQ8 mice, the B cell epitopes subsequently spread to the amino and car

249 shows a cluster of mutations in a predicted B-cell epitope, suggesting immune-avoidance selection.

250 peptides containing the same minimal T- and B-cell epitopes, T1BT*, comprised of a CS-derived univer

251 h a truncated form of OspA that contains the B cell epitope targeted by protective OspA mAb.

252 lapped with regions in histones that contain B cell epitopes targeted by autoantibodies, as well as t

253 the resolution of Lyme disease, the specific B cell epitopes targeted during human infections remain

254 In recent years, identification of B-cell epitopes targeted by neutralizing antibodies has

255 ls from B. bovis-immune cattle and that like B-cell epitopes, Th-cell epitopes are conserved in diffe

256 une oophoritis-inducing T cell epitope and a B cell epitope that induces autoantibody to ZP.

257 caques recognized a limited number of linear B cell epitopes that are highly conserved among orthopox

258 The apoptotic form of U1-70 kd displays B cell epitopes that are not displayed on the intact for

259 Prediction of B cell epitopes that can replace the antigen for antibod

260 topes (5 HLA class I, 36 HLA class II) and 6 B cell epitopes that could serve as promising targets fo

261 we have identified and validated immunogenic B-cell epitopes that are cross-reactive between members

262 out 100 amino acids that encodes immunogenic B-cell epitopes that induce variant-specific antibodies

263 In an independent dataset incorporating 503 B cell epitopes, this method reached accuracy, specifici

264 onstrate previously unknown, highly reactive B cell epitopes throughout the full proteome of SARS-CoV

265 g M5 peptides revealed myosin-cross-reactive B-cell epitopes throughout the A and C repeat regions an

266 cell help was provided by coupling an Abeta B cell epitope to BSA.

267 previously discovered C. pneumoniae-specific B-cell epitopes to 48 peptide antigens from 12 C. pneumo

268 enic RITs by identifying and removing T- and B-cell epitopes to hide the RIT from the immune system.

269 apsid is an efficient vehicle for presenting B-cell epitopes to the immune system, making this a usef

270 iously reported that we could eliminate most B-cell epitopes using a combination of point mutations a

271 The B cell epitope was created by inserting a 12-residue loo

272 from the GAS M protein (J14) representing a B cell epitope was incorporated alongside a universal T

273 The 418-435 B cell epitope was the best candidate both as a vaccine

274 c envelope containing only T-helper (TH) and B-cell epitopes was dependent on CD8+ T cells as well as

275 cell epitopes located within the autoimmune B cell epitope were suppressed in a dominant fashion.

276 The dominant B cell epitopes were conformational and common to both r

277 nd immunogenic MHC class I, MHC class II and B cell epitopes were extracted from top-ranking vaccine

278 elop a multiepitope vaccine, 12 high ranking B cell epitopes were identified from the extracellular d

279 Multiple T and B cell epitopes were identified in Ro60.

280 Ten immunodominant B cell epitopes were identified: CbpD-pep4 (amino acids

281 In contrast, the early dominant B cell epitopes were located in the middle and carboxy p

282 genes of HCV, encoding cytotoxic (CTL), and B cell epitopes were sequenced at 2 time points, 2 years

283 The B cell epitopes were synthesized alone and also linked w

284 Four novel HER-2 B cell epitopes were synthesized as chimeras with a prom

285 In contrast, linear B-cell epitopes were concentrated in the HVR, residing w

286 The predicted T- and B-cell epitopes were further filtered based on the conse

287 The peptide B-cell epitopes were grafted onto the epsilon side chain

288 Several HER-2 B-cell epitopes were identified by computer-aided analys

289 Five linear B-cell epitopes were identified on the rSAHH surface, ex

290 onse against HVR epitopes, T-cell and linear B-cell epitopes were localized by measuring peripheral b

291 Three major linear immunodominant B-cell epitopes were mapped to residues Leu(156) to Ser(

292 alysis of protein antigenicity, and selected B-cell epitopes were synthesized colinearly with a promi

293 Immunization with EGFR B cell epitopes will train the immune system to produce

294 ication and validation of these neutralising B-cell epitopes will provide insights towards the design

295 is a promising vaccine candidate and various B cell epitopes within OprF have been identified.

296 The identification of immunodominant B cell epitopes within surface pneumococcal virulence pr

297 In this study, dominant B-cell epitopes within the acidic (pI 5.35) ankyrin repe

298 Several linear B-cell epitopes within the three proteins were recognize

299 gE Ab responses can be boosted by repetitive B cell epitopes without allergen-specific T cell help by

300 ctor VIII can be reduced by mutagenesis of a B-cell epitope without apparent loss of function, sugges